Background. Fetal membranes are tissues of particular interest for several reasons, including their role in preventing rejection of the fetus and their early embryologic origin. which may entail progenitor potential. The immunologic reactivity and the transplantation potential of amnion and chorion cells, however, remain to be elucidated. Methods. Amnion and chorion cells were isolated from human term placenta and characterized by immunohistochemistry, flow cytometric analysis, and expression profile of relevant genes. The immunomodulatory characteristics of these cells were studied in allogeneic and xenogeneic mixed lymphocyte reactions and their engraftment potential analyzed by transplantation into neonatal swine and rats. Posttransplant chimerism was determined by polymerase chain reaction analysis with probes specific for human DNA. Results. Phenotypic and gene expression studies indicated mesenchymal stem cell-like profiles in both amnion and chorion cells that were positive for neuronal, pulmonary, adhesion, and migration markers. In addition, cells isolated both from amnion and chorion did not induce allogeneic nor xenogeneic lymphocyte proliferation responses and were able to actively suppress lymphocyte responsiveness. Transplantation in neonatal swine and rats resulted in human microchimerism in various organs and tissues. Conclusions. Human amnion and chorion cells from term placenta can successfully engraft neonatal swine and rats. These results may be explained by the peculiar immunologic characteristics and mesenchymal stem cell-like phenotype of these cells. These findings suggest that amnion and chorion cells may represent an advantageous source of progenitor cells with potential applications in a variety of cell therapy and transplantation procedures.
T he amniochorionic membrane delimits the sac that encloses the fetus. The amnion, the innermost layer of the amniotic sac, is lined by a single layer of amniotic epithelial cells (AEC) that reside on a basement membrane and an underlying layer of stromal cells (1) . The chorion leave is composed by the inner chorionic mesoderm similar to the mesenchymal region of the amnion and an outer highly variable trophoblastic layer with extravillous cytotrophoblast cells that represent the only residues of the former villi of the chorion frondosum (2) . Embryologically, the amnion derives from the epiblast of the inner cell mass, whereas the chorion originates from extraembryonic tissues (3) .
Because of their development at very early embryonic stages, AEC have been hypothesized to retain pluripotent potential. Indeed, previous studies reported that human AEC express markers typical of both neuronal (neurofilament, microtubule-associated protein [MAP]-2) and glial cells (glial fibrillary acidic protein), as well as neural progenitors (vimentin, nestin, A2B5) (4, 5) . In addition, these cells are capable of synthesizing and releasing catecholamine (6) and neurotrophic factors such as brain-derived growth factor, neurotrophin-3, and nerve growth factor (7, 8) . These data are corroborated by in vivo experiments indicating that supranigral transplantation of AEC can enhance survival of dopaminergic neurons in rats with 6-hydroxipamine lesions (9) . In addition, AEC have been shown to survive and rescue axotomized neurons from death after transplantation in primates with spinal-cord injury (10) .
Interestingly, Sakuragawa et al. (11) have shown that human AEC also express liver markers such as serum albumin and ␣-fetoprotein, which led to the hypothesis that AEC may be used as a transgene carrier for treatment of inherited liver diseases. Finally, very recent studies showed that cells obtained from amniotic fluid exhibit a stem-cell mesenchymal phenotype similar to that of postnatal bone-marrowderived cells (12) .
The phenotypic and functional characterization of cells of amniochorionic origin, however, is far from complete. In particular, the field has not produced systematic studies of isolated AEC, amniotic stromal cells, or chorionic cells, which are needed to establish whether they all share similar progenitor cell features or expression of differentiation markers.
Another interesting feature of the fetal membrane cells is the low expression of classical major histocompatibility complex (MHC) class I antigens in the presence of expression of the nonclassical HLA-G antigens and lack of MHC of class II molecules (13) . The low immunogenicity of these cells is confirmed by clinical applications of amniotic membranes in surgical procedures where they can be used as a biologic dressing (14) or for treatment of corneal or conjunctival destructive loss (15) . Moreover, in vitro studies have shown that fragments of human amniotic membranes suppress murine alloreactive T-cell responses (16) . However, the immunogenic properties of isolated amniotic and chorionic cells in allogeneic and xenogeneic settings remain to be elucidated. In this study, we set out to investigate the pluripotent potential and immunogenic features of cells derived from term placenta as a first step toward their possible application for allotransplantation.
MATERIALS AND METHODS

Placenta Collection
Upon informed consent, human placentas were obtained at term of normal pregnancies and after caesarean section or vaginal delivery. Samples were kept at room temperature and processed immediately. First, the decidua parietalis was removed by careful scraping. The amnion and chorion leave were then manually separated, and both membranes were washed three times in phosphate-buffered saline (PBS) (Sigma, St. Louis, MO) with 100 U/mL penicillin and 100 g/mL streptomycin (both from Euroclone, Whetherby, UK) and cut into small pieces before enzymatic digestion.
Isolation of Human Amnion and Chorion Cells
Amnion fragments were incubated at 37°C for 5 minutes in PBS containing 2.4 U/mL of dispase (Roche, Mannheim, Germany) followed by six rounds of exposure to 0.25% trypsin (Sigma) in PBS at 37°C for 10 minutes. Resulting cell suspensions were passed through a 100 m cell strainer (BD Falcon, Bedford, MA) and collected by centrifugation (200g for 10 minutes). The remaining tissue fragments were placed in Dulbecco's Minimal Essential Medium (DMEM, Biowhittaker, Verviers, Belgium) containing collagenase (0.75 mg/ mL) (Roche) for 3 hours at 37°C. Cells recovered after this treatment were combined with the fractions collected after the dispase/trypsin steps to constitute a mix of epithelial and stromal cells derived from the amniotic membrane that we refer to hereafter as amnion cells. The chorion fragments, after mechanical removal of decidua, were incubated in dispase, as described, followed by collagenase treatment for 30 minutes. Samples were then subjected to three digestion steps with trypsin for 5 minutes at 37°C. The remaining tissue fragments were further treated with collagenase as above. Dispersed cells were collected by centrifugation after filtration through a 100 m cell strainer. DNase (20 g/mL) (Roche) was added to every enzymatic digestion. Chorion cells were used unfractionated or after depletion of contaminating blood cells using anti-CD45 and anti-glycophorin A (GlyA) immunomagnetic beads following the manufacturer's specifications (Miltenyi Biotec, Bergish Gladbach, Germany).
Flow Cytometry
For evaluation of surface markers expression, cell suspensions were incubated for 20 minutes at 4°C with fluorescein isothiocyanate-or PE-conjugated isotype control or antibodies specific for human CD3 (clone SK7), CD14 (clone MP9), CD29 (clone MAR4), CD34 (clone AC136), CD44 (clone IM7), CD45 (clone H130), CD54 (clone VI A095), CD73 (clone TY/23), CD90 (clone 5E1). All these monoclonal antibodies (mAbs) were purchased from BD Biosciences, San Jose CA. CD105 (clone SN6) was purchased from Serotec, Oxford, UK. Samples were analyzed with a FACSCalibur and the CellQuest software (BD Biosciences).
Immunohistochemistry
Formalin-fixed paraffin embedded tissues were cut at 4 m sections, placed on silane precoated slides, and allowed to dry overnight at 37°C before use. Sections were dewaxed and rehydrated. Endogenous peroxidase activity was suppressed by a 0.3% solution of H 2 O 2 for 10 minutes. For anti-CK19 stainings, a heat-induced epitope retrieval procedure was performed by microwave in citrate buffer before antibody incubation. Incubation with MoAb anti-CD34, CD45RB, and vimentin did not require epitope retrieval. Dilutions of the various antibodies were 1:300 for CD45RB (Dako, Carpenteria CA); 1:100 for CD34 (Caltag, Burlingame CA), CK19 (Delta Biologicals, Pomezia, Italy); 1:50 for vimentin (Dako); and 1:20 for CD31 (Dako).
Mixed Lymphocyte Reaction
Human peripheral blood mononuclear cells (PBMC) were obtained by density gradient centrifugation of heparinized whole blood or buffy coats from healthy donors using Lymphoprep (Axis Shield, Oslo, Norway). PBMC from swine and rats (see Animal Experiments, below) were obtained by density gradient centrifugation of blood samples using Lympholyte Mammals and Lympholyte Murine (Cederlane, Hornby, Canada), respectively. Fresh amnion and chorion cells (the latter unfractionated or after CD45 and GlyA depletion) were resuspended in RPMI 1640 medium supplemented with 10% of heat-inactivated fetal bovine serum (FBS, Sigma). Human PBMC (1ϫ10 5 ) were also resuspended in RPMI 1640 plus FBS and tested as "responders" in cocultures with equal numbers of ␥-irradiated (3,000 rad) amnion or chorion cells as "stimulators." In reciprocal experiments, 1ϫ10 5 amnion or chorion cells were cocultured with ␥-irradiated human PBMC. Xenogeneic mixed lymphocyte reactions (MLR) were performed by culturing 1ϫ10 5 PBMC from experimental control swine with equal numbers of ␥-irradiated human amnion or chorion cells.
All cultures were carried out in triplicate using roundbottom 96-well tissue culture plates (Corning Inc., Corning, NY). Cellular proliferation was assessed after 5 to 6 days of culture by adding 3 H thymidine (1 Ci/well, ICN Biomedicals, Irvine, CA) for 16 to 18 hours. Cells were then harvested with a Filtermate Harvester (Perkin Elmer, Life Sciences, Zaventem, Belgium), and thymidine incorporation was measured with a microplate scintillation and luminescence counter (Top Count NXT, Perkin-Elmer). To study the potential of amnion and chorion cells to suppress alloreactive T-cell responses, 2ϫ10 6 responder PBMC and 2ϫ10 6 alloge-neic ␥-irradiated PBMC were plated in a 24-well tissue-culture plate (Corning) and incubated with a cell suspension of human amniotic or chorionic cells seeded in the upper chamber of a Transwell plate (Corning). Five 6-day cultures were pulsed with 3 H thymidine for 16 to 18 hours before analysis of incorporated radioactivity.
Animal Experiments
All experiments were performed in accordance with the guidelines of the Istituto Zooprofilattico Sperimentale della Lombardia e della Emilia Romagna (IZSLER, Brescia, Italy). All animal studies were approved by the local animal care and use committee. Swine (large white breed) and rats (SpragueDawley, inbred Brescia breed) were raised in and maintained by the IZSLER.
Fresh or cryopreserved amnion or chorion cells, approximately 100ϫ10 6 cells (approximately 7ϫ10 7 cells/kg), were resuspended in 5 mL of PBS with antibiotics (100 U/mL penicillin, 100 g/mL streptomycin, Euroclone) and transplanted into newborn swine at birth by intraperitoneal injection (IP) or by umbilical vein injection (IV) performed during caesarean section (Table 1) . Transplantations in rats were performed IP at day 2 of life using approximately 4ϫ10 6 (approximately 26ϫ10 7 cells/kg) amnion cells resuspended in 100 L of PBS with antibiotics (Table 2) . At variable times after transplantation, animals were killed according with institutional guidelines followed by full necropsies, during which tissue samples were obtained from bone marrow, brain, lung, thymus, kidney, liver, spleen, and immediately frozen in liquid nitrogen.
Chimerism Detection by Polymerase Chain Reaction Analysis
Genomic DNA was extracted from 200 L of peripheral blood or from 10 to 30 mg of various tissues using the Nucleospin Blood or Nucleospin Tissue Kits, respectively (BD Biosciences), according to the manufacturer's instructions. DNA extraction was performed both on samples of treated and untreated experimental animals. In addition, "blank" samples, constituted of PBS aliquots subjected to the same DNA extraction procedure used for the experimental tissue samples, were also generated.
Polymerase chain reaction (PCR) was carried out using an Applied Biosystem 9700 thermal cycler, GeneAmp PCR, and Amplitaq Gold PCR reagents (Applied Biosystems, Foster City, CA). PCR mixtures contained 100 ng of DNA, 200 M dNTPs, and 25 pmol of each primer in a total volume of 50 L. Primers sequences are available upon request. All of the PCR reactions included an initial step at 95°C for 10 minutes. This was followed by 35 cycles (94°C for 30 seconds, 56°C for 30 seconds, 72°C for 1 minute) for the DNA amplification of human mitochondrial cytochrome B oxidase II or 35 cycles (94°C for 1 minute, 60°C for 1 minute, 72°C for 1 minute) for DNA amplification of repetitive ␣-satellite sequence of the centromeric region of human chromosome 17 (17) .
DNA extracted from human peripheral blood was used as a positive control. Confirmation of specific amplification of human mitochondrial cytochrome B oxidase II and human chromosome 17 ␣-satellite target sequences was obtained by automated DNA sequencing and comparison with sequence data deposited in GenBank (accession numbers NC_001807 and M13882, respectively). PCR products were analyzed by agarose gel electrophoresis and ethidium bromide staining.
For Southern Blot analysis, PCR products were subjected to agarose gel electrophoresis, transferred to nylon membranes (Hybond Nϩ, Amersham Biosciences, Little Chalfont, UK), and hybridized to specific probes labeled with horseradish peroxidase enzyme (ECL Gold, Amersham Biosciences). Chemiluminescent signals were detected with a Gel Doc 2000 system (Bio-Rad, Hercules, CA).
Reverse-Transcription PCR Analysis
Total RNA was extracted from 10 to 30 mg of various tissues using the Nucleospin RNA II kit (BD Biosciences) and following the manufacture's instructions. Total RNA (0.5-1 g) was then used for single-strand cDNA synthesis (Super- 
A, amnion cells; C, chorion cells after CD45/glycophorin A depletion; IP, intraperitoneal; IV, intra-umbilical vein; na, sample not available or not adequate for DNA analysis.
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Script II, Invitrogen, Carlsbad, CA). One tenth of the cDNA reaction product was used for amplification with specific primers. Previously reported primer sequences were used for the following genes: OCT4 (18), Notch-1 (19), GATA-2 and Thy-1 (20) , nestin, MAP-2, thyrosine hydroxylase, CD34, CD133 (21), choline acetyltransferase (ChAT) (22) , CD105 (23), CD73 (24), matrix metalloproteinase (MMP)-2 and -9 (25), aquaporin-5 (26), and surfactant protein-A (27) . For all the other genes, primers were designed with Primer Express software (Applied Biosystems), and their sequences are available upon request. The PCR reaction was performed in a total volume of 50 L using 200 M dNTPs, 25 pmol of each primer, and 1.25 U of Taq DNA polymerase (Applied Biosystems). Amplification of hypoxanthine guanine phosphoribosyl transferase (HPRT) was performed on all samples to verify the quality of the cDNA. Reverse-transcription (RT)-PCR amplification products were analyzed by agarose gel electrophoresis followed by ethidium bromide staining. Amplification products for genes of unknown expression characteristics in control cells (e.g., surfactant protein-A, aquaporin 5, Notch-1, octamer binding protein [OCT]-4, and signal transducer and activator of transcription [STAT]-3) were purified using Microcon Centrifugal Filter Devices (Millipore, Bedford, MA) and their sequence verified by automated sequencing using Big Dye Terminator chemistry (Applied Biosystems) on an ABI PRISM 310 Genetic Analyzer (Applied Biosystems).
Statistical Analysis
Comparisons were performed using the two-tail unpaired Student's t test, and differences were considered significant for values of PϽ0.05.
RESULTS
Phenotypical Characterization of Human Amnion and Chorion Cells
Amnion and chorion cells from human term fetal membranes were characterized by immunohistochemical staining (Fig. 1) and showed positivity for epithelial (CK19) and stromal (vimentin) markers. Hematopoietic progenitor and endothelial markers were expressed by chorionic vessel cells, whereas CD45ϩ cells were only found in the cytotrophoblast region. After mechanical separation of amnion and chorion membranes and treatment with trypsin and collagenase, surface antigens expressed by amnion and chorion cell suspensions were analyzed by flow cytometry (Fig. 2) . In contrast with amnion cells, chorion fractions contained CD45ϩ and CD14ϩ cells that were, however, successfully removed after incubation with CD45 immunomagnetic beads.
Additional characterization of amniotic and chorionic cell suspensions using a panel of mAbs specific for mesenchymal stem-cell markers (28) demonstrated positivity of both amnion and chorion cells for CD105 (endoglin), CD29 (beta1 integrin chain), CD44 (receptor for hyaluronan), CD54 (ICAM-1), CD90 (Thy-1), and CD73 (ecto-5'-nucleotidase). In general, higher percentages of positive cells were observed in the chorionic fraction, likely reflective of the higher number of stromal cells found in chorion compared with amnion ( Fig. 1) .
Gene Expression Profile of Human Amnion and Chorion Cells
The phenotypical characterization for amnion and chorion cells was extended using RT-PCR analysis of gene 
na, sample not available or not adequate for DNA analysis. expression. We found that both amnion and chorion cells expressed CD105, CD73, CD90, and fetal-liver kinase-1 (Fig.  3A) . Expression of these markers together with CD29, CD166, and very late antigen (VLA)-5 ( Fig. 3B ) and in the absence of CD45 (Fig. 3A) suggests that amnion and chorion cells may have mesenchymal stem-cell characteristics (28) . Expression of cell-adhesion molecules and integrins such as L-selectin, alpha M beta 2 integrin, VLA-5, CD29, p-selectin ligand-1, and the matrix receptors CD44 and CD166 was demonstrated in both amnion and CD45-GlyA-depleted chorion cells, thus suggesting migration capabilities of these cells. VLA-4 and leukocyte function associated antigen-1 genes were also clearly expressed in chorion cells (Fig. 3B) . Presence of CD34 and CD133 (Fig. 3A) was detected in CD45-GlyA-chorionic cells, which is likely caused by commixture of these cells with endothelial cells from fetal blood vessels, as shown in Figure 1E . Furthermore, we investigated the expression of genes coding for molecules involved in extracellular matrix maintenance and remodelling. We found that the MMP-2 and MMP-9 were expressed in both amnion and chorion cells, whereas expression of MMP-12 was only detected in chorion samples (Fig. 3C) .
Among markers of neural differentiation, expression of MAP-2 and ChAT were detected only in amnion cells, whereas both nestin and thyrosine hydroxylase showed strong signals in both amnion and chorion cell samples. Of note, with the exception of nestin, neither umbilical cord nor peripheral blood control cells expressed these markers (Fig.  3D) .
In addition, we investigated the expression of two pneumocytes markers, surfactant protein-A (a type II-pneumocyte marker) and aquaporin-5 (a type I pneumocyte marker) that were both expressed by amnion and chorion cells (Fig. 3E) . Finally, expression of transcription factors OCT-4, GATA-2, STAT-3, and Notch-1 receptor was also detected in both amnion and chorion cells (Fig. 3F) .
Human Amnion and Chorion Cells Fail to Induce Allogeneic and Xenogeneic Lymphocyte Reaction
PBMC from healthy, allogeneic donors were mixed with ␥-irradiated human amnion or chorion cells, and their proliferation was assessed by thymidine incorporation after 6 days of culture. In contrast with the positive MLR response induced by irradiated control allogeneic human PBMC, amnion cells had no stimulatory effect (Fig. 4A) . On the contrary, chorion cells were able to stimulate allogeneic lymphocytes (Fig. 4B) as well as to proliferate after stimulation with allogeneic PBMC in a MLR (data not shown). However, after CD45-GlyA-depletion, chorion cells did not elicit PBMC proliferation, suggesting that the positive MLR observed using unfractionated chorion cells was most likely caused by the presence of peripheral blood cells known to reside in atrophic trophoblastic villi (Fig. 4B) .
The immunogenic potential of human amnion and chorion cells was also tested in a xenogeneic model by coculturing them with PBMC obtained from adult untreated swine. The results of these experiments showed that, although porcine PBMC proliferated when stimulated with control human PBMC, no lymphocyte reaction was observed in response to the presence of amniotic cells or CD45-GlyA-chorion cells (Fig. 5) .
Human Amnion and Chorion Cells Inhibit Allogeneic Mixed Lymphocyte Reaction
It has been previously reported that fragments of human amniotic membrane can induce down-regulation of allogenic murine MLR (16) . We studied the effects of isolated amnion and chorion cells after addition to a human allogeneic MLR using a Transwell filter system. Both amnion and CD45-GlyA-chorion cells were able to suppress allogeneic MLR, as shown in Figure 6 .
Human Amnion and Chorion Cells Engraft Newborn Swine and Rats
Newborn swine received transplants immediately after birth of amnion cells (2 animals), chorion cells (2 animals), or a mixture (1:1) of amnion and chorion cells (3 animals). Approximately 100ϫ10 6 cells (approximately 7ϫ10 7 cells/kg) were injected either IP or IV (umbilical vein).
Treated animals were killed at different time points after transplantation, as shown in Table 1 . Multiple samples from bone marrow, brain, lung, thymus, kidney, liver, and spleen were tested for human microchimerism using two independent highly repetitive DNA regions (human mitochondrial cytochrome B oxidase II gene and human chromosome 17 ␣-satellite). Results of preliminary optimization efforts indicated our amplification conditions were such that human mitochondrial cytochrome B oxidase II target sequences from one human cell diluted into 2ϫ10 6 xenogeneic cells could be successfully amplified (Parolini et al., manuscript in preparation).
Negative control samples included tissue obtained from untreated animals and "blank" PBS samples. Tissue samples were scored positive for microchimerism if PCR products for both human target genes were detected in at least two DNA samples independently extracted from the same tissue and if the relative "blank" samples returned no amplification signal.
Under these conditions, human microchimerism was detected in bone marrow, brain, lung, and thymus in all treated animals and all time points with the exception of one animal showing negative signal in brain and thymus on day 48 after transplantation. Samples from kidney, liver, and spleen showed chimerism in two animals at 72 to 120 days after transplantation (Table 1) . Interestingly, the two animals analyzed at the longest time points showed the most widespread evidence of human microchimerism. No clear differences in patterns of microchimerism were noted among animals receiving transplants with different types of human cells (amnion or chorion cells) or subjected to different routes of transplantation (IP or IV). All samples from control untreated animals were negative for human microchimerism.
Eleven neonatal rats were injected IP with approximately 4ϫ10 6 amnion cells (approximately26ϫ10 7 cells/kg). From 14 to 90 days after transplantation, animals were killed, and tissue samples were processed to detect human DNA chimerism, as described above. Similar to the results obtained in swine, human microchimerism was demonstrated in bone marrow, brain, lung, and thymus of most rats receiving transplantation (Table 2 ). Similar to that observed in swine receiving transplantation, rats analyzed at later time points showed a more disseminated evidence of human microchimerism.
DISCUSSION
Cells of amniochorionic membrane origin are receiving recently renewed interest in the fields of regenerative medicine and cell transplantation. Amniotic membranes have been used extensively as biologic dressings in ophthalmic, abdominal, and plastic surgery (14, 15, 29) . More recently, however, the ability of AEC to express neuronal cell markers (4) have stimulated investigations into their potential use as source of cell therapy for neurologic conditions such as Parkinson's disease (30) and spinal cord injury (10) . AEC are also able to express hepatic cell markers (11) , which is interpreted as supporting evidence for the presence of undifferentiated multipotent progenitor cells among AEC and suggests their possible use for therapeutic approaches of liver disorders. Furthermore, AEC have been shown to have the potential to differentiate into pancreatic ␤-cells (31) .
Whether all or only a particular fraction of AEC possess these characteristics, is not clear. In addition, the potential role of amniotic stromal cells and chorion cells has not been investigated.
Amnion and chorion cells analyzed in our study represent heterogeneous cell populations originating from stromal, epithelial, and vascular tissue. Phenotypical analysis showed a pattern compatible with mesenchymal progenitors (28) , similar to what was recently observed in cells isolated from amniotic fluid (12) . Moreover, RT-PCR analysis revealed expression of pulmonary markers (surfactant protein-A, aquaporin-5) in both amnion and chorion cell preparations, similar to the findings in bone-marrow mesenchymal cells (32) . Finally, we detected expression of transcription factors that are indicative of active cell proliferation (33, 34) , thus suggesting that amnion and chorion cells maintain clear functional characteristics, even in term placentas.
Importantly, chorion cells shared most of amnion cells' gene expression pattern characteristics, with the notable exception of few markers (CD34 and CD133, MAP2, ChAT, MMP-12). These differences may be not surprising considering that the two membranes have different embryologic origin and physiologic functions during pregnancy. The chorion membrane derives from extraembryonic tissue that give rise to the trophoblast, whereas the amnion membrane develops from the epiblast, which also gives origin to the neuronal notochord. The different embryologic origin could explain the specificity of neuronal cell markers expressed in amnion cells. The expression of CD34 and CD133 endothelial cell precursor markers in chorion cells is likely caused by the presence of residual fetal vascular structures in atrophic trophoblastic villi found in the chorion but absent in the amnion. Differences in expression of MMPs by amnion and chorion have been previously reported (35) , and changes in the adhesion molecule expression are likely associated with the uterine invasion process that is specific of the cytotrophoblast tissue (36) .
The results of our in vivo experiments begin to explore the functional characteristics of amnion and chorion cells.
Previous studies have clearly demonstrated that combining the use of undifferentiated donor tissues and immunologically immature recipients is sufficient to achieve long-lasting microchimerism (Ͻ1% donor cells) in neonatal mice and other animal models (37) (38) (39) . We were therefore prompted to attempt transplantation of human amnion and chorion cells into newborn swine and rats to test their engraftment capability. Chimerism determination demonstrated that these cells can migrate and colonize specific organs such as brain, bone marrow, lung, and thymus. Although we have not formally demonstrated that transplanted cells acquired the specific characteristics of the various tissues from which they were recovered, these findings support the tantalizing although unproven possibility that amnion and chorion cells may be able to differentiate into a variety of specific tissues. Because current levels of engrafted human cells are insufficient to detect macrochimerism by flow cytometric or immunohistology analysis, we will attempt to verify the differentiation potential of amnion and chorion cells in future in vivo studies in which chimerism level will be increased by subjecting recipient animal to tissue injury before transplantation of human cells (40) .
In general, human chimerism was detected at most time points in brain, lung, bone marrow, and thymus, whereas spleen, kidney, and liver were mostly positive for human cells in animals killed at later intervals. The expression or neuronal and pulmonary markers detected in amnion and chorion cells may help justify the early tropism of these cells for host brain and lung tissues. It is important to remember that in most cases, amniotic and chorionic cells were transplanted IP and that finding of DNA chimerism in different organs is indicative of active cell migration, which is consistent with the findings of expression of adhesion and migration molecules, as well as cell proliferation transcription factors by the transplanted cells.
The low expression of rare MHC class I molecules and lack of MHC class II expression by fetal membrane cells is thought to explain their avoidance of immune recognition by allogeneic T cells. Accordingly, engraftment of amnion and chorion cells in xenogeneic models may be the result of their evading or even actively suppressing the host immune response. The results of our in vitro studies confirm that amnion and chorion fail to induce both allogeneic and xenogeneic lymphocyte responsiveness. In addition, amnion and CD45-GlyA-chorion cells were found capable to suppress allogeneic human MLR, even when direct cell contact was prevented by a Transwell membrane, suggesting active secretion of soluble inhibitors. These results are consistent with previous reports showing that human amniotic membrane fragments added to murine MLR can suppress murine alloreactive T-cell response (16) and the existence of a low molecular weight molecule named lymphocyte proliferation inhibiting factor that has been isolated from human placenta cultures and shown to suppress human and murine MLR (41) .
In conclusion, our data demonstrate that both amnion and chorion cells from term placenta express genes specific for migratory cellular functions such as adhesion molecules, cell proliferation, and progenitor markers. Such combination is reminiscent of that described for mesenchymal stem cells. The capability of these cells to engraft different organs after IP transplantation indicate active migration characteristics with homing and long-term persistence within the local tissue environment.
It is important to note that heterogenous cell populations have been used in these proof-of-concept studies. Further in vitro and in vivo experiments with fractionated amnion and chorion cells are warranted to characterize immunologic behavior and transplantation potential of purified subpopulation of cells isolated from fetal membranes to verify that they display bona fide mesenchymal progenitor characteristics and to compare them with mesenchymal cells from other tissue sources. It will be of special interest to describe the differentiation and progenitor potential of characterized amnion and chorion subpopulations, their migration patterns and homing characteristics, and their capacity to induce tolerance after transplantation.
The current results add to the rapidly expanding field of interest in the potential research and therapeutic application of the fetal amniochorionic membranes. The need for universal donor tissues in clinical transplantation is critical, and fetal membranes are an extremely attractive source of progenitor cells because they are easily available and free from ethical concerns. The definition of their potential beyond the role of biologic dressing is becoming therefore increasingly important.
